Test Module 2

We acknowledge the urgency of catalysing a step-change in political support and financing for the ACT- Accelerator in order to enable it to deliver on its mission of accelerating the discovery and deployment of new COVID-19 tools to all people, everywhere.

Roles: Everyone: All Users

Regions: Norway , South Africa

Topics: Coronavirus (COVID-19), Global Health

Today Dr Tedros Adhanom Ghebreyesus, WHO Director-General, and Dr Ursula von der Leyen, President of the European Commission, co-hosted the inaugural meeting of the Access to COVID-19 Tools (ACT) Accelerator Facilitation Council.

Roles: Everyone: All Users

Regions: Canada , China, France , Italy , Norway , Rwanda , South Africa , United Kingdom , Uzbekistan

Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health

Two years into the World Health Organization’s (WHO) ambitious effort to eliminate industrially produced trans fats from the global food supply, the Organization reports that 58 countries so far have introduced laws that will protect 3.2 billion people from the harmful substance by the end of 2021. But more than 100 countries still need to take actions to remove these harmful substances from their food supplies.

Consumption of industrially produced trans fats are estimated to cause arou

Roles: Everyone: All Users

Regions: Canada , Iran , Nigeria , Turkey , United Kingdom , United States

Topics: Coronavirus (COVID-19), Energy, Global Health

This letter will focus largely on WHO’s efforts to address the double challenge of malaria & COVID-19. Our work in recent months has been carried out in close collaboration with country-based experts and global partners. We are very grateful to all of our partners for their ongoing commitment and contributions.

Roles: Everyone: All Users

Regions: Chad , China, France , Italy , Rwanda , Sierra Leone , United Kingdom

Topics: Coronavirus (COVID-19), Global Health

Pregnant women with COVID-19 are less likely than non-pregnant women with COVID-19 to have symptoms, but more likely to need intensive care if severely ill – according to new findings

New research findings published today in the BMJ help to shed light on the risks of COVID-19 for pregnant women and their babies. The paper suggests that pregnant women seen at the hospital with suspected or confirmed COVID-19 are less likely to

Roles: Everyone: All Users

Regions: United Kingdom

Topics: Coronavirus (COVID-19), Global Health

Joint release by the World Health Organization, United for Global Mental Health and the World Federation for Mental Health

Mental health is one of the most neglected areas of public health. Close to 1 billion people are living with a mental disorder, 3 million people die every year from the harmful use of alcohol and one person dies every 40 seconds by suicide. And now, billions of people around the world have been affected by the COVID-19 pandemic, which is having a furth

Roles: Everyone: All Users

Regions: Argentina, Peru , United Kingdom , United States

Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Global Health, Human Rights and Democracy, Refugee and Humanitarian Assistance

The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.

One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T

Roles: Everyone: All Users

Regions: Canada , France , Italy , United Kingdom

Topics: Global Health

• Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world
  
• 80 potentially self-financing countries have submitted non-binding expressions of interest to the Gavi-coor

  Roles: Everyone: All Users

  Regions: Afghanistan, Argentina, Canada , Chile, China, France , Ireland , Norway , Tonga , United Kingdom , United States , West Bank , Zambia

  Topics: Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Energy, Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

• WHO Information Notice for Users of Medical Devices 2020/3

  Date: 7 August 2020

  Subject: Substandard/Falsified medical devices and personal protective equipment (PPE) used in the context of the COVID-19 pandemic

  WHO-identifier: 2020/3, version 1

  Type of action: Advice to users of medical devices and PPE used for prevention, treatment and care for COVID-19.<

  Roles: Everyone: All Users

  Regions: United Kingdom

  Topics: Climate and Environment, Coronavirus (COVID-19), Energy, Global Health

• Statement on the fourth meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of coronavirus disease (COVID-19)

  The fourth meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the coronavirus disease (COVID-19) took place on Friday, 31 July 2020 from 12:00 to 17:45 Geneva time (CEST). 

  Proceedings of the meeting

  Members and advisors of the Emergency Committee were convened by vid

  Roles: Everyone: All Users

  Regions: United Kingdom

  Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

• INFOSAN Quarterly Summary, 2020 #2

  During the second quarter of 2020, the INFOSAN Secretariat has been involved in 29 food safety incidents with 59 WHO Member States and two territories of WHO Member States. There were 13 biological hazard incidents (Salmonella [5], Listeria monocytogenes [3], Clostridium botulinum [2], Vibrio cholerae [1], and two involving an unspecified biological hazard), six with a chemical hazard (methanol [3], histamine [2] and patulin [1]), five involving an undeclared allergen (cashew and pistachio [1], sesame [1],

  Roles: Everyone: All Users

  Regions: Australia , Cambodia , Canada , China, Dominican Republic , France , Hong Kong , Mexico , Singapore , United States

  Topics: Combating Drugs and Crime, Coronavirus (COVID-19), Energy, Global Health

• Framework for the evaluation of new tests for tuberculosis infection

  WHO and the Stop TB Partnership’s New Diagnostics Working Group (NDWG) launched today a framework for the evaluation of new tests for tuberculosis infection. The document provides details on study design, populations, reference standards, sample size calculation and data analysis to guide the future development of these tests.
  

  Approximately a quarter of th

  Roles: Everyone: All Users

  Regions: Italy

  Topics: Global Health

• New COVID-19 Law Lab to provide vital legal information and support for the global COVID-19 response

  Launching today, the COVID-19 Law Lab initiative gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the pandemic. The goal is to ensure that laws protect the health and wellbeing of individuals and communities and that they adhere to international human rights standards.
  

  The new Lab (at www.COVIDLawLab.org) is a joint project of United Nations D

  Roles: Everyone: All Users

  Regions: United Kingdom

  Topics: Climate and Environment, Combating Drugs and Crime, Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation

• More than 150 countries engaged in COVID-19 vaccine global access facility

  • Seventy-five countries submit expressions of interest to COVAX Facility, joining up to 90 further countries which could be supported by the COVAX Advance Market Commitment (AMC)
  • The COVAX Facility, and the AMC within it, is designed to guarantee rapid, fair and equitable access to COVID-19 vaccines for every country in the world, rich and poor, to make rapid progress towards slowing the pandemic 
    
  • Interest from governments represen

    Roles: Everyone: All Users

    Regions: Argentina, Canada , Norway , United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance, Science, Technology, and Innovation

  • #EndTB Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment

    A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.

    Roles: Everyone: All Users

    Regions: United Kingdom

    Topics: Global Health, Science, Technology, and Innovation

  • Public statement for collaboration on COVID-19 vaccine development

    Roles: Everyone: All Users

    Regions: Argentina, Canada , Chad , China, Norway , United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

  • A meeting on digital innovations, TB and implementation research organised by WHO and the European Respiratory Society

    Roles: Everyone: All Users

    Regions: Tanzania , Ukraine , United Kingdom

    Topics: Global Health, Science, Technology, and Innovation

  • Strengthening accountability to end TB

    Roles: Everyone: All Users

    Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

  • Children’s story book released to help children and young people cope with COVID-19

    Roles: Everyone: All Users

    Regions: United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Refugee and Humanitarian Assistance

  • WHO Timeline - COVID-19

    Roles: Everyone: All Users

    Regions: Canada , China, Singapore , United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

  • WHO and partners call for urgent investment in nurses

    Roles: Everyone: All Users

    Regions: United Kingdom

    Topics: Coronavirus (COVID-19), Global Health, Global Women's Issues, Science, Technology, and Innovation

  • WHO and UNICEF to partner on pandemic response through COVID-19 Solidarity Response Fund

    Roles: Everyone: All Users

    Topics: Coronavirus (COVID-19), Global Health, Science, Technology, and Innovation

  Results 1 - 22 of 22